Similar articles for PMID: 16648324

Year	Number of Results
1975	1
1977	1
1980	1
1984	5
1985	1
1986	6
1987	1
1990	2
1991	3
1992	1
1993	9
1994	4
1995	6
1996	2
1997	2
1998	2
1999	6
2000	2
2001	3
2002	6
2003	5
2004	12
2005	11
2006	10
2007	26
2008	19
2009	16
2010	14
2011	13
2012	10
2013	3
2014	7
2015	3
2016	8
2017	4
2018	8
2019	4
2020	6
2021	4
2022	1

1

Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.

Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P. Nickel MK, et al. Am J Psychiatry. 2006 May;163(5):833-8. doi: 10.1176/ajp.2006.163.5.833. Am J Psychiatry. 2006. PMID: 16648324 Clinical Trial.

2

Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.

Bellino S, Paradiso E, Bogetto F. Bellino S, et al. Psychiatry Res. 2008 Nov 30;161(2):206-12. doi: 10.1016/j.psychres.2007.07.006. Epub 2008 Oct 9. Psychiatry Res. 2008. PMID: 18848360

3

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up.

Nickel MK, Loew TH, Pedrosa Gil F. Nickel MK, et al. Psychopharmacology (Berl). 2007 May;191(4):1023-6. doi: 10.1007/s00213-007-0740-0. Epub 2007 Feb 23. Psychopharmacology (Berl). 2007. PMID: 17318503 Clinical Trial.

4

Aripiprazole pharmacotherapy of borderline personality disorder.

Mobascher A, Mobascher J, Schlemper V, Winterer G, Malevani J. Mobascher A, et al. Pharmacopsychiatry. 2006 May;39(3):111-2. doi: 10.1055/s-2006-941485. Pharmacopsychiatry. 2006. PMID: 16721700

5

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study.

Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, Nickel MK. Tritt K, et al. J Psychopharmacol. 2005 May;19(3):287-91. doi: 10.1177/0269881105051540. J Psychopharmacol. 2005. PMID: 15888514 Clinical Trial.

6

Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH. Nickel MK, et al. J Clin Psychiatry. 2004 Nov;65(11):1515-9. doi: 10.4088/jcp.v65n1112. J Clin Psychiatry. 2004. PMID: 15554765 Clinical Trial.

7

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL. Lin CH, et al. J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db. J Clin Psychopharmacol. 2011. PMID: 21869699 Clinical Trial.

8

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F. Bellino S, et al. J Clin Psychiatry. 2006 Jul;67(7):1042-6. doi: 10.4088/jcp.v67n0705. J Clin Psychiatry. 2006. PMID: 16889446 Clinical Trial.

9

Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.

Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C. Loew TH, et al. J Clin Psychopharmacol. 2006 Feb;26(1):61-6. doi: 10.1097/01.jcp.0000195113.61291.48. J Clin Psychopharmacol. 2006. PMID: 16415708 Clinical Trial.

10

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.

Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR. Potkin SG, et al. Arch Gen Psychiatry. 2003 Jul;60(7):681-90. doi: 10.1001/archpsyc.60.7.681. Arch Gen Psychiatry. 2003. PMID: 12860772 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed